Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

Healthcare Biotechnology
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Satellos Bioscience Inc Com > This Decline is shocking
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by AcynicalJedion Jul 24, 2018 7:53pm
146 Views
Post# 28362184

RE:This Decline is shocking

RE:This Decline is shocking
Jaytee123 wrote: .275 to .12 in 9 trading days? 


Is it really? ICO hasn't even started phase 2 trials yet. Sure results from phase 1 were positive. But phase to is where therapies either make it or break it. This simply got way ahead of itself. If the bleeding stops and SP consolidates here it's still looking at a 130% gain on good phase 1 news which seems pretty reasonable. Give this another 6-12 months and "If" phase 2 yields favorable results you could certainly be looking at a multi dollar SP possibly much more.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities